You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Metastatic Renal Cell Carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Learn About First and Later Lines of Medicines in Treating

Completed
  • Metastatic Renal Cell Carcinoma
    • New York, New York
      Pfizer Headquarters
    May 12, 2023

    Renal Cell Carcinoma Trial (Cytoreductive Nephrectomy)

    Not yet recruiting
    • Renal Cell Carcinoma
    • Cytoreductive Nephrectomy
    • (no location specified)
    Jul 3, 2023

    Metastatic Renal Cell Carcinoma Trial in Cleveland (Nivolumab, Ipilimumab)

    Active, not recruiting
    • Metastatic Renal Cell Carcinoma
    • Cleveland, Ohio
      Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
    Jan 25, 2023

    go Back Into Records and Observe How People With Metastatic

    Not yet recruiting
    • Carcinoma, Renal Cell
    • Clear-cell Metastatic Renal Cell Carcinoma
    • Istanbul, Turkey
      Pfizer
    Feb 15, 2023

    Renal Cell Carcinoma Trial in Beijing, Seoul (RO7247669, Tiragolumab, Pembrolizumab)

    Recruiting
    • Renal Cell Carcinoma
    • Beijing, China
    • +1 more
    Mar 28, 2023

    Kidney Cancer, Clear Cell Renal Cell Carcinoma Metastatic, Synchronous Tumor Trial in Seoul (Cytoreductive

    Recruiting
    • Kidney Cancer
    • +2 more
    • Cytoreductive nephrectomy±metastasectomy
    • Human-derived materials sampling
    • Seoul, Korea, Republic of
      Yonsei University Health System, Severance Hospital
    Mar 2, 2023

    ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

    Not yet recruiting
    • ccRCC
    • +20 more
    • (no location specified)
    Jul 6, 2023

    Renal Cell Carcinoma Trial in Houston (Perfusion CT scan)

    Active, not recruiting
    • Renal Cell Carcinoma
    • Perfusion CT scan
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Dec 6, 2022

    Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Kidney Cancer Trial in Boston (Implantable Microdevice (IMD))

    Not yet recruiting
    • Renal Cell Carcinoma
    • +2 more
    • Implantable Microdevice (IMD)
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Jan 17, 2023

    Immunophenotyping in Metastatic Kidney Cancer Patients Receiving

    Recruiting
    • Metastatic Renal Cell Carcinoma
    • Stage IV Renal Cell Cancer AJCC v8
    • Biospecimen Collection
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 6, 2023

    Metastatic Renal Cell Carcinoma Trial in France (Cabozantinib)

    Recruiting
    • Metastatic Renal Cell Carcinoma
    • Angers, France
    • +8 more
    Dec 5, 2022

    Renal Clear Cell Carcinoma, Renal Papillary Cell Carcinoma Trial in London (Savolitinib, MEDI4736, Tremelimumab)

    Active, not recruiting
    • Renal Clear Cell Carcinoma
    • Renal Papillary Cell Carcinoma
    • London, United Kingdom
      Thomas Powles
    Aug 10, 2022

    Renal Cell Carcinoma Trial (Pembrolizumab)

    Completed
    Has Results
    • Renal Cell Carcinoma
    • Pembrolizumab
    • (no location specified)
    Aug 17, 2022

    Advanced Clear Cell Renal Cell Carcinoma, Advanced Papillary Renal Cell Carcinoma, Advanced Renal Cell Carcinoma Trial in Duarte

    Recruiting
    • Advanced Clear Cell Renal Cell Carcinoma
    • +11 more
    • Cabozantinib S-malate
    • +2 more
    • Duarte, California
      City of Hope Medical Center
    Nov 22, 2022

    Metastatic Renal Cell Carcinoma, Clear-cell Metastatic Renal Cell Carcinoma Trial in Philadelphia (Cabozantinib)

    Recruiting
    • Metastatic Renal Cell Carcinoma
    • Clear-cell Metastatic Renal Cell Carcinoma
    • Philadelphia, Pennsylvania
      Fox Chase Cancer Center
    Mar 2, 2022

    Kidney Cancer Trial in Birmingham (Acarbose Tablets)

    Not yet recruiting
    • Kidney Cancer
    • Acarbose Tablets
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Aug 2, 2022

    Metastatic Renal Cell Carcinoma Trial in United Kingdom (Cyclophosphamide 50mg, Pembrolizumab 25 mg/1 ML Intravenous Solution

    Recruiting
    • Metastatic Renal Cell Carcinoma
    • Cyclophosphamide 50mg
    • Pembrolizumab 25 mg/1 ML Intravenous Solution [KEYTRUDA]
    • Cambridge, United Kingdom
    • +3 more
    Aug 22, 2022

    Metastatic Renal Cell Carcinoma Trial in Lebanon, Burlington (Sunitinib, Temsirolimus)

    Active, not recruiting
    • Metastatic Renal Cell Carcinoma
    • Lebanon, New Hampshire
    • +1 more
    Aug 9, 2022

    Metastatic Renal Cell Carcinoma, Brain Metastases Trial in United States (drug, device, radiation)

    Recruiting
    • Metastatic Renal Cell Carcinoma
    • Brain Metastases
    • Basking Ridge, New Jersey
    • +6 more
    Nov 10, 2023

    Metastatic Melanoma, Advanced Locoregional Melanoma, Metastatic Renal Cell Carcinoma Trial run by the National Cancer Institute

    Recruiting
    • Metastatic Melanoma
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 20, 2022

    Clear Cell Renal Cell Carcinoma, Sarcomatoid Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Trial in Duarte

    Recruiting
    • Clear Cell Renal Cell Carcinoma
    • +3 more
    • Biospecimen Collection
    • +6 more
    • Duarte, California
      City of Hope Medical Center
    Sep 19, 2023

    Advanced Ovarian Carcinoma, Advanced Renal Cell Carcinoma, Advanced Pancreatic Carcinoma Trial in Bydgoszcz, Otwock, Warsaw

    Recruiting
    • Advanced Ovarian Carcinoma
    • +7 more
    • Bydgoszcz, Kujawsko-pomorskie, Poland
    • +2 more
    Mar 7, 2023

    Nivolumab Plus Ipilimumab in Renal Cell Cancer in Real World

    Active, not recruiting
    • Advanced or Metastatic Renal Cell Carcinoma
      • Tokyo, Japan
        Local Institution - 0001
      May 25, 2022

      Clear-cell Metastatic Renal Cell Carcinoma Trial in Guangzhou (Drug: Pembrolizumab)

      Not yet recruiting
      • Clear-cell Metastatic Renal Cell Carcinoma
      • Drug: Pembrolizumab
      • Guangzhou, Guangdong, China
      • +1 more
      Oct 7, 2022

      Japanese RCC Patients Treated With Avelumab Plus Axitinib as

      Not yet recruiting
      • Renal Cell Carcinoma
      • (no location specified)
      Jan 18, 2023